LIMN

Liminatus Pharma

• Reuters·6d ago

  Liminatus Pharma FY25 net loss widens to $10.2 million; operating loss narrows to $3 million

• TipRanks·03/17 12:16

  Liminatus Pharma to initiate Phase 1 clinical trial for IBA101 antibody

• Benzinga·03/17 12:14

  Liminatus Intends To Start Phase 1 Clinical Study Of CD47-Blocking Monoclonal Antibody

• Reuters·03/17 12:08

  Liminatus Pharma plans Phase 1 trial of CD47 antibody IBA101 in lung cancer

• Reuters·03/17 12:08

  LIMINATUS PHARMA ANNOUNCES PLANNED PHASE 1 CLINICAL TRIAL OF IBA101, A NEXT-GENERATION CD47 BLOCKING ANTIBODY

• TipRanks·03/04 22:25

  Liminatus Pharma Lowers Quorum Requirement in Bylaw Amendment

• Reuters·03/04 21:17

  Liminatus Pharma Cuts Shareholder Meeting Quorum to One-Third

• Benzinga·02/19 09:25

  Why Etsy Shares Are Trading Higher By Over 15%; Here Are 20 Stocks Moving Premarket

• TipRanks·02/18 22:57

  Liminatus Pharma Completes $4 Million Public Equity Offering

• Benzinga·02/17 17:14

  Gold Down 3%; Medtronic Earnings Top Views

• Benzinga·02/17 17:05

  12 Health Care Stocks Moving In Tuesday's Intraday Session

• Benzinga·02/17 14:46

  US Stocks Mixed; NY Manufacturing Activity Falls In February

• TipRanks·02/17 13:55

  Liminatus Pharma prices 13.8M shares at 29c in public offering

• Benzinga·02/17 13:47

  Liminatus Announces $4M Public Offering; 13,813,000 Common Stock Shares On Offer At $0.29/Share

• Reuters·02/17 13:44

  Liminatus Pharma Announces $4 Million Public Offering With Warrants